Tag: AbolerIS Pharma

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Phone

This field is for validation purposes and should be left unchanged.

HomeTagsAbolerIS Pharma

Building the AI-First Gulf: How GCC Enterprises Are Entering the Next Digital Era

SPCL 成为 SpaceX 上市首日首个且唯一提供 2 倍杠杆风险敞口的美国 ETF

Huawei Cloud Becomes Thailand’s First with Government-Recognized HCCDX Certification Program

Tag: AbolerIS Pharma

AbolerIS Pharma Presents New Data Supporting CD45RC as a Novel Therapeutic Target and Potential Biomarker in Sjögren’s Disease at EULAR 2026

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us